DNA adducts of ortho-toluidine in human bladder

Biomarkers

Volumn 16, Issue 2, 2011, Pages 120-128

  Böhm, Francine ^a   Schmid, Dagmar ^a   Denzinger, Stefan ^b   Wieland, Wolf F ^b   Richter, Elmar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

4 aminobiphenyl; carcinogenicity; gas chromatography; mass spectrometry; smoking

Indexed keywords

4 BIPHENYLAMINE; DNA; TOLUIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; BLADDER EPITHELIUM; BLADDER MUCOSA; BLADDER TUMOR; CANCER TISSUE; DNA ADDUCT; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS FRAGMENTOGRAPHY; SUDDEN DEATH;

AMINOBIPHENYL COMPOUNDS; AUTOPSY; BIOPSY; CARCINOGENS; CHROMATOGRAPHY, GAS; DEATH, SUDDEN; DNA; DNA ADDUCTS; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; TOLUIDINES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79951872499     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.534556     Document Type: Article

References (57)

1. Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G, Peluso M, Hautefeuille A, Malaveille C, Vineis P. 2002. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 23:861-866. (Pubitemid 34567527)
2. Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F., Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens - Part F: chemical agents and related occupations. Lancet Oncol 10:1143-1144.
3. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Cogliano V. 2008. Carcinogenicity of some aromatic amines, organic dyes, and related exposures. Lancet Oncol 9:322-323.
4. Bayraktar N, Kilic S, Bayraktar MR, Aksoy N. 2010. Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study. J Clin Lab Anal 24:25-30.
5. Bessette EE, Spivack SD, Goodenough AK, Wang T, Pinto S, Kadlubar FF, Turesky RJ. 2010. Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chem Res Toxicol 23:1234-1244.
6. Branco PS, Antunes AMM, Marques MM, Chiarelli MP, Lobo AM, Prabhakar S. 1999. New syntheses of DNA adducts from methylated anilines present in tobacco smoke. Chem Res Toxicol 12:1223-1233. (Pubitemid 30013533)
7. Brock WJ, Hundley SG, Lieder PH. 1990. Hepatic macromolecular binding and tissue distribution of ortho- and para-toluidine in rats. Toxicol Lett 54:317-325.
8. Culp SJ, Roberts DW, Talaska G, Lang NP, Fu PF, Lay JO, Teitel CH, Snawder JE, von Tungeln LS, Kadlubar FF. 1997. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat Res 378:97-112. (Pubitemid 27342088)
9. DeBord DG, Swearengin TF, Cheever KL, Booth-Jones AD, Wissinger LA. 1992. Binding characteristics of ortho-toluidine to rat hemoglobin and albumin. Arch Toxicol 66:231-236.
10. DFG 2006. List of MAK and BAT values 2006. D-69451 Weinheim, Germany: Wiley-VCH Verlag GmbH
11. Diaz Gómez MI, Fanelli SL, Delgado de Layño AM, Castro JA, Castro GD. 2006. Liver nuclear and microsomal CYP2E1-mediated metabolism of xenobiotics in rats chronically drinking an alcohol-containing liquid diet. Toxicol Ind Health 22:367-374. (Pubitemid 46713465)
12. Dinsmore WW, Wyllie MG. 2009. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int 103:940-949.
13. Duan J-D, Jeffrey AM, Williams GM. 2008. Assessment of the medicines lidocaine, prilocaine and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. Drug Meta Dispos 36:1470-1475.
14. El-Bayoumy K, Donahue JM, Hecht SS, Hoffmann D. 1986. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res 46:6064-6067. (Pubitemid 17221730)
15. Elmansouri A, Outzourhit A, Lachkar A, Hadik N, Abouelaoualim A, Achour ME, Oueriagli A, Ameziane EL. 2009. Influence of the counter ion on the properties of poly(o-toluidine) thin films and their Schottky diodes. Synth Met 159:292-297.
16. Gaber K, Harréus UA, Matthias C, Kleinsasser NH, Richter E. 2007. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine. Toxicology 229:157-164. (Pubitemid 44881170)
17. Gan J, Skipper PL, Gago-Dominguez M, Arakawa K, Ross RK, Yu MC, Tannenbaum SR. 2004. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst 96:1425-1431. (Pubitemid 39429666)
18. Grimmer G, Dettbarn G, Seidel A, Jacob J. 2000. Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 247:81-90. (Pubitemid 30068687)
19. Grimmer G, Schneider D, Naujack K-W, Dettbarn G, Jacob J. 1995. Intercept-reactant method for the determination of aromatic amines in mainstream tobacco smoke. Beitr Tabakforsch Int 16:141-156. (Pubitemid 126120556)
20. Haglund J, Henderson AP, Golding BT, Törnqvist M. 2002. Evidence for phosphate adducts in DNA from mice treated with 4-(N- methyl-N-nitrosamino)-1- (3-pyridyl)-1-butanone (NNK). Chem Res Toxicol 15:773-779. (Pubitemid 34663617)
21. Heppel CW, Heling A-K, Richter E. 2009. Ultrasensitive method for the determination of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts by gas chromatography-high resolution mass spectrometry in mucosal biopsies of the lower esophagus. Anal Bioanal Chem 393:1525-1530.
22. Hölzle D, Schlöbe D, Tricker AR, Richter E. 2007. Mass spectrometric analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in human lung. Toxicology 232:277-285. (Pubitemid 46441620)
23. IARC. 2009. Overall evaluations of carcinogenicity to humans. http:// monographs.iarc.fr/ENG/Classification/index.php
24. IFOP. 2001. Azofarbstoffe, die in krebserzeugende Amine gemäβ TRGS 614 (Ausgabe März 2001) spalten können. http://www. vci.de/template-downloads/tmp-VCIInternet/115196AzoTR614. pdf?DokNr = 115196&p = 101
25. Jones CR, Sabbioni G. 2003. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. Chem Res Toxicol 16:1251-1263. (Pubitemid 37315215)
26. Korinth G, Weiss T, Penkert S, Schaller KH, Angerer J, Drexler H. 2007. Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams. Occup Environ Med 64:366-372. (Pubitemid 46867137)
27. Kütting B, Göen T, Schwegler U, Fromme H, Uter W, Angerer J, Drexler H. 2009. Monoarylamines in the general population - A crosssectional population-based study including 1004 Bavarian subjects. Int J Hyg Environ Health 212:298-309.
28. Kutzer C, Branner B, Zwickenpflug W, Richter E. 1997. Simultaneous solid-phase extraction and gas chromatographic-mass spectrometric determination of hemoglobin adducts from tobaccospecific nitrosamines and aromatic amines. J Chromatogr Sci 35:1-6. (Pubitemid 127477122)
29. Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. 2007a. Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N′OElig;-nitrosonornicotine. Chem Res Toxicol 20:246-256. (Pubitemid 46408861)
30. Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. 2007b. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol. Chem Res Toxicol 20:235-245. (Pubitemid 46408860)
31. Lewalter J, Gries W. 2000. Haemoglobin adducts of aromatic amines: aniline, o-, m- and p-toluidine, o-anisidine, p-chloroaniline, á- and â-naphthylamine, 4-aminodiphenyl, benzidine, 4,4′- diaminodiphenylmethane, 3,3′-dichlorobenzidine. In: Greim H, editor. Analyses of Hazardous Substances in Biological Materials. Vol. 7. D-69469 Weinheim, Germany: Wiley-VCH Verlag GmbH. p 191-218.
32. Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP, Kadlubar FF. 1994. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect 102 (Suppl.6):11-16. (Pubitemid 24364871)
33. Lindenblatt N, Belusa L, Tiefenbach B, Schareck W, Olbrisch RR. 2004. Prilocaine plasma levels and methemoglobinemia in patients undergoing tumescent liposuction involving less than 2,000 ml. Aesth Plast Surg 28:435-440. (Pubitemid 40685179)
34. Marques MM, Mourato LLG, Santos MA, Beland FA. 1996. Synthesis, characterization, and conformational analysis of DNA adducts from methylated anilines present in tobacco smoke. Chem Res Toxicol 9:99-108. (Pubitemid 26042852)
35. Martone T, Airoldi L, Magagnotti C, Coda R, Randone D, Malaveille C, Avanzi G, Merletti F, Hautefeuille A, Vineis P. 1998. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int J Cancer 75:512-516. (Pubitemid 28094094)
36. Mourato LLG, Beland FA, Marques MM. 1999. 32P-postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies. Chem Res Toxicol 12:661-669. (Pubitemid 29354750)
37. Neurath GB, D̈nger M, Pein FG, Ambrosius D, Schreiber O. 1977. Primary and secondary amines in the human environment. Food Cosmet Toxicol 15:275-282. (Pubitemid 8166642)
38. OECD. 2004. SIDS initial assessment report, o-toluidine. http://www. chem.unep.ch/irptc/sids/oecdsids/95534.pdf
39. Palmiotto G, Pieraccini G, Moneti G, Dolara P. 2001. Determination of the levels of aromatic amines in indoor and outdoor air in Italy. Chemosphere 43:355-361. (Pubitemid 32231641)
40. Patrianakos C, Hoffmann D. 1979. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3:150-154. (Pubitemid 9242012)
41. Pliss GB. 2004. Experimental study of ortho-toluidine carcinogenicity. Voprosy onkologii 50:567-571. (Pubitemid 39523929)
42. Randall KL, Argoti D, Paonessa JD, Ding Y, Oaks Z, Zhang Y, Vouros P. 2010. An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues. J Chromatogr A 1217:4135-4143.
43. Richter E, Branner B. 2002. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B 778:49-62.
44. Ricicki EM, Soglia JR, Teitel C, Kane R, Kadlubar F, Vouros P. 2005. Detection and quantification of N-(deoxyguanosin-8-yl)-4- aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chem Res Toxicol 18:692-699. (Pubitemid 40563283)
45. Riedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR. 2006. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 30:187-195. (Pubitemid 44285276)
46. Sabbioni G, Richter E. 1999. Aromatic amines, nitroarenes, and heterocyclic amines. In: Marquardt H, Schäfer SG, McClellan R, Welch F, editors. Toxicology. San Diego, CA, USA: Academic Press. p 729-774.
47. Sch́te-Borkovec K, Heppel CW, Heling A-K, Richter E. 2009. Analysis of myosmine, cotinine and nicotine in human toenail, plasma and saliva. Biomarkers 14:278-284.
48. Skipper PL, Kim MY, Sun H-LP, Wogan GN, Tannenbaum SR. 2010. Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis 31:50-58.
49. Stabbert R, Schäfer K-H, Biefel C, Rustemeier K. 2003. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom 17:2125-2132. (Pubitemid 37098328)
50. Stepanov I, Hecht SS. 2005. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 14:885-891. (Pubitemid 40478552)
51. Stiborova M, Miksanova M, Havlicek V, Schmeiser HH, Frei E. 2002. Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat Res 500:49-66. (Pubitemid 34219425)
52. Stiborova M, Schmeiser HH, Breuer A, Frei E. 2001. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation. Gen Physiol Biophys 20:267-279. (Pubitemid 33040354)
53. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P. 1991. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1:61-66.
54. Thompson PA, DeMarini D, Kadlubar FF, McClure GY, Brooks LR, Green BL, Fares MY, Stone A, Josephy PD, Ambrosone CB. 2002. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen 39:134-142. (Pubitemid 34260485)
55. Tricker AR. 2006. Biomarkers derived from nicotine and its metabolites: a review. Beitr Tabakforsch Int 22:147-175. (Pubitemid 44727346)
56. Ward EM, Sabbioni G, DeBord DG, Teass AW, Brown KK, Talaska GG, Roberts DR, Ruder AM, Streicher RP. 1996. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J Natl Cancer Inst 88:1046-1052. (Pubitemid 26260490)
57. Zayas B, Stillwell SW, Wishnok JS, Trudel LJ, Skipper P, Yu MC, Tannenbaum SR, Wogan GN. 2007. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis 28:342-349. (Pubitemid 46321849)